logo
Germany's infrastructure push needs more than money

Germany's infrastructure push needs more than money

Yahoo21-05-2025
As construction crews using heavy excavators demolished a major highway bridge in Berlin, pensioner Guido, like many Germans, greeted the dusty spectacle with grim satisfaction.
"For once, it was very quick, it took about a month," said the 65-year-old, who only gave his first name, adding that "we're not used to our projects going according to plan".
A crack first appeared a decade ago in a support structure of the concrete and steel bridge built in 1963 that forms part of the capital city's busy A100 ring road.
After the crack recently widened alarmingly, work to take down the bridge finally started in March, leaving piles of rubble below.
Thousands watching the demolition on an internet livestream were happy to see the start of a multi-million-euro renovation project but were upset it took so long.
The case is symptomatic of a problem facing the world's third-biggest economy: an enormous backlog of crumbling infrastructure that needs replacing at a cost of hundreds of billions.
Thousands of roads and bridges, many from the 1960s and 1970s, are reaching the end of their lifespans, and little has been done for years as governments have shied away from major spending.
Germany's new Chancellor Friedrich Merz has pledged to give Europe's top economy a facelift that is also set to include new railway tracks, school buildings and telecom lines.
Even before he took office, his coalition managed to have the previous parliament pass a gigantic 500-billion-euro ($563 billion) infrastructure fund dubbed a spending "bazooka".
- Wake-up call -
After years of fiscal restraint, Germans are crying out for action: an end to patchy mobile phone signals, late trains, slow internet and potholed roads.
A dramatic wake-up call came in September, when a 400-metre-long (1,300-foot-long) bridge collapsed in the eastern city of Dresden, with large sections crashing into the Elbe river.
Luckily it happened overnight, averting a potentially deadly disaster, but the incident made Germany's infrastructure malaise a major election campaign theme.
Germany's bridges need 100 billion euros' worth of repairs and upgrades, according to the European Federation for Transport and Environment (T&E).
Along German motorways and major roads, one third of bridges need to be reconstructed entirely, said the Brussels-based group.
The need is all the more pressing since the last government "embellished" progress, according to a report from the Federal Court of Audit, which found that just 40 percent of bridge renovations planned for 2024 were actually completed.
The new government's fund, intended to be spent over 12 years, should help -- but many local politicians aren't holding their breath.
"Money alone solves nothing," scoffed Steffen Scheller, mayor of the eastern town of Brandenburg an der Havel, an hour's drive from Berlin.
Scheller is hoping for 90 million euros from the fund but said there is another, major problem: "We have a shortage of qualified project managers and engineers."
Bureaucracy can also slow down the process, he said.
A new bridge was built in 2023 over a congested level crossing outside of the city, but has stood unused since. Before it can open, safety barriers must be built.
But the project was pushed back to 2026 after some companies complained that proper procedure had not been followed in the tender process.
- 'Fanciful projects' -
"I've given up all hope of ever using the bridge," said motorist Fransiska, stuck in a traffic jam caused by the closure.
The 38-year-old hospital worker said her commute takes about an hour longer than it used to.
Most of the town's 70 bridges were built back in East Germany's communist days, using substandard steel. Several of them are now closed to heavy goods vehicles, causing problems as they reroute.
Brandenburgers are particularly distraught at the delay in rebuilding a bridge in the town centre that had been promised for 2022.
The delay means "local business really struggles with transport" while the town faces higher pollution, Scheller said.
Benedikt Heyl, author of the T&E report, said Merz had demonstrated "ambition" to tackle the problem.
But Heyl said the new transport minister, Patrick Schnieder, should do better than renovate the 4,000 bridges he has promised by 2030.
Merz should put "fanciful projects" for new motorways on pause, Heyl said, and work on the basics, such as making sure construction companies have long-term contracts that allow them to plan for the future.
First of all, he said, the central government must take a thorough stocktake of the scale of the problem.
"The data is often very poor," Heyl said. "Local authorities often know how bridges are doing. But nobody has an overview at the national level."
kas-vbw/fz/rmb/rsc
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Zero-G Biology
Zero-G Biology

Los Angeles Times

time21 minutes ago

  • Los Angeles Times

Zero-G Biology

El Segundo-based Varda Space Industries is using space-based technology to manufacture complex pharmaceuticals in orbit, leveraging microgravity to create unique drug formulations for clients. — An El Segundo company has a novel solution to creating complex pharmaceuticals – using space tech to launch them into orbit The next frontier for medicine is closer to Los Angeles than San Francisco but feels like another galaxy. That's because it's about 300 miles straight up above sea level – in low-Earth orbit. Varda Space Industries, an El Segundo microgravity-enabled life sciences company, uses low-Earth orbit to develop unique drug formulations. It's a space-age approach to medicine that launches a capsule containing chemical compounds beyond Earth's atmosphere, where microgravity allows pharmaceutical formulations to be created in a process differently than on the surface. The capsules then reenter the atmosphere with their precious cargo. It became the first company to complete a manufacturing mission conducted outside of the International Space Station last year. Two more missions followed in early 2025 and a fourth launched on June 22. Varda plans to launch one more capsule this year and has four scheduled in 2026, which are all booked to capacity. 'What's special about next year is that the last two capsules will be going up on the same rocket. It will be the first time where we have two spacecraft in orbit at once, and we'll start to move into a fleet mentality,' said Will Bruey, chief executive and co-founder of Varda. Bruey, a former SpaceX engineer co-founded the company in 2021 with Delian Asparouhov, a former principal at Khosla Ventures. The company's growth is supported by a new round of investment. In July, the company announced a $187-million Series C round led by Natural Capital and Shrug Capital, with participation from Founders Fund, Peter Thiel, Khosla Ventures, Caffeinated Capital, Lux Capital and Also Capital. That brings total funding to $329 million. It will use the additional funds to scale operations so that it an expand its capsule production capacity, as well as open additional ground test facilities for pharmaceutical development. Additional capacity could eventually help lower costs – the average mission costs several million dollars today, although the finances are not measured by traditional revenue figures because there is potential to structure deals with royalties from the research and development conducted now. To support its additional manufacturing capabilities, it signed a 10,000-square-foot lease near its El Segundo headquarters for a dedicated lab space that will design molecules and test them prior to launch. The new laboratory will facilitate more complex experiments and allow it to research small molecules and move into more complex biologics. It currently has roughly 130 employees, and that number could increase to 180 within the next 12 months. Bruey envisions a time when there is a steady stream of capsules launching into, and returning from, space for biotech research, with launches on a weekly or daily basis. The company envisions scaling operations by launching more frequently, rather than trying to increase the size of their capsules to accommodate more experiments at a single launch. He likened it to his first job as a pizza delivery driver where the goal was to deliver many pizzas hot and fast to a large number of customers rather than waiting for a large order that required a semitruck to make the delivery. The capsules and satellite buses that carry them are constructed at the company's 61,000-square-foot headquarters where it forges raw materials into space vehicles. Those are then transported to Vandenberg Space Force Base up the coast near Santa Barbara for launch aboard a SpaceX rocket. Reusable rockets have lowered the cost of access to space and opened a range of in-space activities. Increased launch capabilities from companies, such as Long Beach-based Relativity Space, could lower costs even further as the lower-earth-orbit economy becomes more attainable as a destination for manufacturing, biotech, data centers and other technologies. Inside of the Varda capsule, custom-made lab equipment holds raw components that are mixed to form the targeted chemical compound. The device itself is small – measuring less than two feet tall by one foot wide. It has proprietary technology that is different from lab equipment on Earth. For example, a gas bubble that forms during an experiment on Earth would escape due to gravity, but it's not able to do so in space, so the equipment needs to account for environmental factors. Molecules could take a day or more to form, so the capsule remains in space for an extended period of time to complete the experiment. It also must preserve the temperature during re-entry and secure it from vibrations to ensure that the molecule is not destroyed. The capsule re-enters the atmosphere at speeds that reach Mach 25. Re-entry is supervised at the company's mission control center inside the headquarters building, where teams oversee both the capsule re-entry and its novel cargo. The capsule acts like a hypersonic wind tunnel at top speeds, so Varda has secured contracts with NASA and the Department of Defense to test materials for other applications beyond pharmeceutical development. This is also a third line of business – microgravity testing on materials for government and private clients – similar to the way that experiments are conducted on the International Space Station but with full automation and with the results delivered faster and at a lower cost than waiting for transportation to and from the space station. The typical Varda mission can last about two months. Varda is the first and only company to receive a special vehicle operator license under FAA Part 450. The W-4 mission is the first time the agency has issued that license, which allows it to reenter W-series capsules as needed without submitting new safety methodologies to the FAA for each identical flight. It has permission from the FAA to reenter capsules through 2029 before needing to renew the license. The W-4 mission is the maiden flight for Varda's next-generation spacecraft, which includes an in-house platform to navigate the spacecraft during the mission. While in orbit, the satellite bus provides the capsule with power, communications, attitude control and propulsion. When the capsule is ready for re-entry, it separates from the satellite bus and reenters, where it is recovered. Several startups have conducted test flights, such as German firm Atmos Space Cargo, California-based Outpost Space and Inversion Space, but none of these companies have successfully launched and landed a commercial mission. Meanwhile, SpaceX is reportedly interested in developing similar biotech capabilities to Varda. In some ways, the competition has helped Varda by lending validity to its approach to the larger biotech community, which is taking greater interest due to more capacity and competition. 'More people are getting to see the huge opportunity. We're actually pretty excited,' said Bruey. 'We've collaborated with SpaceX the last five years. Our partnership right now is focused on the launch aspect, and we'll continue to collaborate.' In February, Colorado-based Sierra Space, a commercial space and defense company that is building the Dream Chaser spaceplane, announced initiatives to advance research and development of biopharmaceutical solutions in low-Earth orbit during its inaugural mission to the International Space Station. Plans include conducting experiments to identify new ways to deliver cancer therapies to patients on Earth in collaboration with Merck. Another challenge for Varda is companies that are developing commercial space stations, such as Axiom Space, Blue Origin and Starlab Space. While these are in current development, they still have several years before they could come online. 'Once the commercial space stations have real estate in space, they will sell capacity or manufacturing,' said Dr. Leon Alkalai, chief executive at Mandala Space Ventures (and an investor in Varda). However, Varda has a real advantage built in to its ethos. 'Rather than thinking of manufacturing as a service, Varda is making it part of their core competency and betting on the value-add component to make themselves part of the value chain.' Overall, the space economy currently generates $613 billion in revenue, according to a recent report from The Space Foundation, which tracks revenue and spending on space technology. It projects that the space economy could grow to $1 trillion by 2032 at the current growth rate. Asparouhov credited an experiment published by pharmaceutical developer Merck in 2019 regarding the International Space Station as inspiration for Varda. That experiment demonstrated microgravity could develop higher-quality and more uniform crystallization. The applications could lead to new drug formations or entirely new medicines. For example, there is potential for medication that needs to be given intravenously to be recalibrated into a shelf-stable pill format. The company focus is both a biotech formulation platform and a space operation. It doesn't discover the molecules or choose what targets to go after. Rather, its business is to work within the pharmaceutical supply chain during the manufacturing process to open formulations that wouldn't otherwise exist. In a sense, the Varda system is a specialized piece of lab equipment that can introduce a new type of environment for biotech research. Bruey likened it to the introduction of other technologies such as cold and refrigeration, which have major implications on drug development. Crystallization and growth continue on Earth following the initial microgravity development. It's akin to a sourdough starter, which can be expanded to many loaves of bread once it's initially formed. Crystallization processes are commonly used in the manufacture of small molecules and small protein therapeutics. However, it has been challenging to identify the optimal crystallization processes for biologic drugs due to their large size and the flexibility of their structure. Once the drugs are developed, they are still required to go through testing, clinical trials and would need regulatory approval. A traditional drug development timeline could take a decade on average, and Bruey stated that he hopes that Varda's initial microgravity molecules could be available by the end of the decade for commercial use. 'The partners that we have see us as a pharmaceutical company. They don't see us as a space company. They bring us a drug that is having a particular problem, and we go solve it for them and hand it back,' said Asparouhov.

From Seoul to the World: Anti Social Social Club Launches 'Designed in Korea' Line
From Seoul to the World: Anti Social Social Club Launches 'Designed in Korea' Line

Hypebeast

time3 hours ago

  • Hypebeast

From Seoul to the World: Anti Social Social Club Launches 'Designed in Korea' Line

Summary Following the milestone opening of its first global flagship store in South Korea earlier this year,Anti Social Social Club(ASSC) has launched its 'Designed in Korea' capsule collection. The line fuses the brand's early‑era identity with the contemporary creative energy of Seoul, resulting in a curated range of premium apparel and accessories. Each capsule will release in limited quantities, underscoring the label's reputation for exclusivity and collectability. The debut drop features heavyweight tees, fleece, jackets, hats, and accessories, all crafted from elevated materials with meticulous attention to detail. ASSC's Seoul‑based design team revisited the brand's archives to reinterpret signature graphics and silhouettes through a modern Korean lens, creating pieces that balance nostalgia with fresh, street‑ready appeal. Offered in sizes M through 2XL, the range is designed to cater to a broad audience while retaining ASSC's distinctive edge. With prices ranging from $42 – $121 USD, the 'Designed in Korea' line positions itself as an accessible yet premium addition to the streetwear market. Drop 1 is available now exclusively through Anti Social Social Club's officialwebsite.

AT&T Inc. (T) Named No. 1 in J.D. Power 2025 Business Internet Satisfaction Study; Announces Dual Listing on NYSE Texas
AT&T Inc. (T) Named No. 1 in J.D. Power 2025 Business Internet Satisfaction Study; Announces Dual Listing on NYSE Texas

Yahoo

time3 hours ago

  • Yahoo

AT&T Inc. (T) Named No. 1 in J.D. Power 2025 Business Internet Satisfaction Study; Announces Dual Listing on NYSE Texas

AT&T Inc. (NYSE:T) is included in our list of the . A close-up of a telecom tower amid a backdrop of urban skylines, symbolizing the growth and development of telecommunications services. On August 11, 2025, AT&T Inc. (NYSE:T) announced that it was named No. 1 in Customer Satisfaction for Medium Business and Large Enterprise Internet Service in the J.D. Power 2025 Business Internet Satisfaction Study. This is the company's eighth consecutive win for Large Enterprise and third consecutive win for Medium Business, highlighting its leading reputation for delivering high-performance fiber and 5G connectivity to over 2.5 million enterprises globally. Meanwhile, on July 31, 2025, AT&T Inc. (NYSE:T) announced its dual listing on NYSE Texas, effective August 1, 2025. The company will retain its primary NYSE listing. This achievement enhances investor access in a pro-business market. With its Communication and Latin America segments, AT&T Inc. (NYSE:T) offers telecommunications and technology services globally. It is included in our list of the most undervalued value stocks to buy. While we acknowledge the potential of T as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: 13 Best Oil Refinery Stocks to Buy Right Now and 7 Best Potash Stocks to Buy According to Analysts. Disclosure: None. Sign in to access your portfolio

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store